?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
March 24, 2025 signalgroup
Biosimilars Forum Chair of Scientific Affairs Committee to Speak at the Festival of Biologics USA
News
December 12, 2024 Katie Quinn
Biosimilars Forum Welcomes Henlius as Newest Member
News
August 15, 2024 Katie Quinn
Biosimilars Forum Calls on CMS to Support Lower-Cost Biosimilars and Increase Access for Patients
News
July 24, 2024 signalgroup
The Biosimilars Forum Supports House Committee on Oversight and Accountability Probe Into the PBM Monopoly
News
July 9, 2024 signalgroup
Biosimilars Forum Calls for Reform of the PBM Monopoly
News
March 20, 2024 signalgroup
Biosimilars Forum Announces Support for Increasing Access to Biosimilars Act
News
March 14, 2024 signalgroup
Biosimilars Forum Urges Congress to Support Free Market Competition and Lower Prescription Drug Prices for Patients by Reforming Pharmacy Benefit Managers
News
January 24, 2024 signalgroup
Biosimilars Forum Welcomes Teva as Newest Member
News
January 10, 2024 signalgroup
Biosimilars Forum Welcomes Biocon Biologics as Newest Member
News
November 30, 2023 signalgroup
Julian Malasi Member Spotlight
  • Prev page
  • 01
  • 02
  • 03
  • 04
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us